ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugEnable Biotech AG
Enable Biotech AG Logo
Verified· 2 sources

Enable Biotech AG

Summary

About the company

The core activity of Enable Biotech is the development and manufacturing of cell and gene therapies (ATMPs) as well as exosome therapies for clinical trials. The company offers Contract Development and Manufacturing Organization (CDMO) services, including process development, clinical manufacturing, quality control, and regulatory support. Enable Biotech focuses on the needs of start-ups and small companies in the field of advanced therapies, providing flexible and cost-effective solutions for the production of cell and gene therapies.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered7
CDMO services for Cell & Gene Therapy
CDMO services for the development and clinical manufacture of cell, gene-modified cell, and exosome therapies, with CMC expertise, process development, and GMP production.
Clinical GMP manufacturing of cell therapies
Clinical GMP manufacturing of cell therapies, including production with PBMC, T cells, NK cells, iPSCs, MSC and HLSCs, as well as QC release testing.
Clinical GMP manufacturing of gene therapies
Clinical GMP manufacturing of gene therapies, with gene editing via viral vectors such as AAV and LVV or electroporation, as well as support for clinical development.
Clinical GMP manufacturing of exosome therapies
Clinical GMP manufacturing of exosome therapies, including development, production and characterization in the context of cell & gene therapy.
CMC and regulatory submission support
Preparation of CMC sections in regulatory submissions, with support for early clinical development programs and upcoming regulatory requirements.

Knowledge

No knowledge articles yet

Once Enable Biotech AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Enable Biotech AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Enable Biotech AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Enable Biotech AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Baarerstrasse 8
6300 Zug

At a glance

Legal form
Corporation
UID
CHE-461.204.999
Founded
2023 · 3 years
Last commercial register change
December 29, 2025
Employees
11 to 20

Similar companies

BS
Bristol-Myers Squibb Products SA
Steinhausen
SC
Swiss Cardio Technologies AG
Rotkreuz
TP
Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug
Zug
VA
Vesifact AG
Baar